Marina Yazykova, an Employee of the Institute of Natural and Mathematical Sciences, Took Part in the European Biotechnology Congress 2024

Member of the Institute of Natural and Mathematical Sciences of Samara University, Doctor of Biological Sciences, Professor of the Department of Biochemistry, Biotechnology and Bioengineering Marina Yazykova took part in the European Biotechnology Congress 2024 held in Istanbul from October 3 to 5 as an invited speaker and chair of the section "Medical Biotechnology".

The European Biotechnology Association (EBTNA) was established in 1996 by the EU countries to coordinate and promote research in various fields of biotechnology; implement, advise and monitor educational programs in the field of biotechnology; as well as engage the business community in implementing biotechnological developments and supporting innovative start-ups.

87 oral presentations and more than 700 posters were presented at the congress. The topics of the reports encompassed all modern approaches and achievements of biotechnology. Nevertheless, the main emphasis was placed on medical biotechnology, in particular individual human genomic studies and, as a result, targeted therapy, CRISPR – CAS genome editing, the effect of nanoparticles on cellular structures, modeling of molecular processes in various pathologies, and the use of artificial intelligence to search for rare genetic mutations. New data on mRNAs "reading frames" encoding previously unknown mammalian and plant proteins were presented. Interesting studies also concerned the study of the human microbiome, its associated duration and quality of life. Several reports were related to stem cells, in particular, a report on the cytokine profile of mesenchymal stem cells depending on cultivation conditions. Achievements in 3D printing of tissues and organs (pancreas, blood vessels, heart muscle) were shown in real time.

Marina Yazykova's report, presented at the congress and selected for oral presentation by the EBTNA organizing committee, presented the results on the effect of low concentrations of metal nanoparticles up to 50 nm in size on human red blood cells. An interesting fact is that a report on the development of Alzheimer's disease associated with the content of copper nanoparticles in brain cells was presented at the congress. The data and information materials obtained during the congress will be used to implement the communication strategy of the Institute of Natural and Mathematical Sciences, as well as applied in scientific research.

M.Yu. Yazykova was awarded a certificate of honor from the European Congress on Biotechnology 2024 for her presentation and work as the chair of the section.